News & Insights

Insights

De Novo Design of Progressable Antibodies to Therapeutic Targets

Our X-Design team reports success in using AI to rapidly create drug-like antibody leads for one pipeline target and in drugging a separate undruggable pipeline target.

See more
See more
De Novo Design of Progressable Antibodies to Therapeutic Targets
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Buzzy AI biotech Xaira reveals antibody platform, first taste of pipeline

Buzzy AI biotech Xaira reveals antibody platform, first taste of pipeline

October 2, 2026
News
De Novo Design of Progressable Antibodies to Therapeutic Targets

De Novo Design of Progressable Antibodies to Therapeutic Targets

October 2, 2026
Insights
Xaira wins the 2026 Fierce AI Innovation Award for Preclinical Development

Xaira wins the 2026 Fierce AI Innovation Award for Preclinical Development

September 2, 2026
News
Curious about Xaira's approach to building better AI for drug discovery?

Curious about Xaira's approach to building better AI for drug discovery?

July 21, 2026
News
Xaira Therapeutics Announces the Appointment of Dr. Ian McCaffery as SVP, Translational Science and Early Clinical Development, and the Promotions of Dr. Ci Chu to Chief Discovery Officer and Dr. Bo Wang to Chief AI Scientist

Xaira Therapeutics Announces the Appointment of Dr. Ian McCaffery as SVP, Translational Science and Early Clinical Development, and the Promotions of Dr. Ci Chu to Chief Discovery Officer and Dr. Bo Wang to Chief AI Scientist

July 6, 2026
Press Releases
Progressable Binders: The Binders that Matter

Progressable Binders: The Binders that Matter

June 29, 2026
Insights